WO2009060621A1 - 術後の癒着を抑制するための医療用組成物 - Google Patents

術後の癒着を抑制するための医療用組成物 Download PDF

Info

Publication number
WO2009060621A1
WO2009060621A1 PCT/JP2008/003228 JP2008003228W WO2009060621A1 WO 2009060621 A1 WO2009060621 A1 WO 2009060621A1 JP 2008003228 W JP2008003228 W JP 2008003228W WO 2009060621 A1 WO2009060621 A1 WO 2009060621A1
Authority
WO
WIPO (PCT)
Prior art keywords
medical composition
surgical adhesion
preventing post
adhesion
post
Prior art date
Application number
PCT/JP2008/003228
Other languages
English (en)
French (fr)
Inventor
Shouji Ooya
Tetsuo Hiratou
Kentaro Nakamura
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of WO2009060621A1 publication Critical patent/WO2009060621A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

　本発明の目的は、薬剤貯蔵、徐放用担体としての機能を保持しつつ、特に心筋組織での繊維組織形成を抑制し、かつ、周辺組織との癒着を抑制することができる医療用組成物を提供することである。本発明によれば、架橋されたアルブミンを含有する、術後の癒着を抑制するための医療用組成物が提供される。  
PCT/JP2008/003228 2007-11-08 2008-11-07 術後の癒着を抑制するための医療用組成物 WO2009060621A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-290552 2007-11-08
JP2007290552 2007-11-08

Publications (1)

Publication Number Publication Date
WO2009060621A1 true WO2009060621A1 (ja) 2009-05-14

Family

ID=40625528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/003228 WO2009060621A1 (ja) 2007-11-08 2008-11-07 術後の癒着を抑制するための医療用組成物

Country Status (1)

Country Link
WO (1) WO2009060621A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362856A (zh) * 2011-11-02 2012-02-29 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子外用溶液

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020310A (ja) * 2000-06-30 2002-01-23 Nipro Corp 組織癒着防止剤
WO2006016600A1 (ja) * 2004-08-10 2006-02-16 National Institute For Materials Science 酒石酸誘導体及び該誘導体により合成された高分子架橋体
WO2006085653A1 (ja) * 2005-02-14 2006-08-17 Medgel Corporation 医療用ハイドロゲル
WO2006136870A1 (fr) * 2005-06-21 2006-12-28 Antoine Turzi Hydrogel bioresorbable

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020310A (ja) * 2000-06-30 2002-01-23 Nipro Corp 組織癒着防止剤
WO2006016600A1 (ja) * 2004-08-10 2006-02-16 National Institute For Materials Science 酒石酸誘導体及び該誘導体により合成された高分子架橋体
WO2006085653A1 (ja) * 2005-02-14 2006-08-17 Medgel Corporation 医療用ハイドロゲル
WO2006136870A1 (fr) * 2005-06-21 2006-12-28 Antoine Turzi Hydrogel bioresorbable

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"The Society of Polymer Science, Japan Preprints of Research Group on Biochemical Polymer Symposium, 23 July, 2007 (23.07.07)", vol. 36TH, article YASUMUNE YAMAZOE: "Kessei Albumin o Mochiita Saibo Setchaku Seigyo", pages: 1 - 2 *
MOTOYUKI SUZUKI ET AL.: "Setchaku Izonsei Dobutsu Saibo no Fuchaku ni Oyobosu Kessei Tanpaku no Eikyo", MONTHLY JOURNAL OF INSTITUTE OF INDUSTRIAL SCIENCE, vol. 41, no. 3, March 1989 (1989-03-01), pages 175 - 178 *
YASUMUNE YAMAZOE ET AL.: "Kessei Albumin Film no Sakusei to Sono Bussei ni Kansuru Kenkyu", POLYMER PREPRINTS, JAPAN, vol. 50, no. 5, 7 May 2001 (2001-05-07), pages 1012 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362856A (zh) * 2011-11-02 2012-02-29 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子外用溶液

Similar Documents

Publication Publication Date Title
PE20081175A1 (es) Derivados de ftalazinona
USD648137S1 (en) Absorbent paper
MY154909A (en) Novel thiophene derivatives
WO2008128028A3 (en) Solifenacin compositions
MY153985A (en) Aminotriazole derivatives as alx agonists
EP2059626A4 (en) FLUID DISTRIBUTION BASED ON SOLID PRECURSORS USING SOLIDS WITH CONTROLLED MORPHOLOGY
IL200684A0 (en) Heterocyclic cyclopamine analog compounds, compositions comprising the same and uses thereof
WO2006050221A3 (en) Porous photonic crystals for drug delivery to the eye
WO2010037854A3 (fr) Forme pharmaceutique orale a base de microgranules a liberation prolongee resistante a l' alcool
WO2007120855A3 (en) Safety cast
WO2009059701A3 (de) Retardtabletten mit hydromorphon
WO2010043978A3 (en) Matrix for tissue repair
IL205057A0 (en) Pyrimidyl indoline compound, composition comprising the same and uses thereof
MY151452A (en) Triazole derivative
MX2010001574A (es) Ligandos del receptor cannabinoide.
WO2007139804A3 (en) Compositions and methods for treating conditions of the nail unit
WO2011077239A3 (en) Slow release pharmaceutical compositions of iloperidone
WO2010078538A3 (en) Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
WO2012066488A3 (en) Bridged spiro[2.4]heptane ester derivatives
WO2011126839A3 (en) Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
USD629114S1 (en) Set of bandages for a healing wound
IN2012DN00311A (ja)
WO2010007441A3 (en) Phosphopeptides and use of the same
USD640371S1 (en) Absorbent article
USD647612S1 (en) Tampon

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08848105

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08848105

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP